About Transverse Medical
Transverse Medical is a private company based in Denver, Colorado. It has reported $24,517,316 raised in five offerings on Form D since May 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | Dec 10, 2024 | $10,000,000of $11.2M target | 2 | $5.0M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 14, 2023 | Aug 18, 2023 | $6,627,316fully sold | 31 | $213K | EquityRule 506(b) | Form D ↗ |
| Nov 6, 2019 | Nov 21, 2019 | $140,000of $5.0M target | 3 | $46,667 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 18, 2018 | Oct 3, 2018 | $7,750,000of $9.7M target | 48 | $161K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | May 24, 2017 | $0of $3.0M target | 0 | — | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $24,517,316 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Transverse Medical's Form D filed Dec 10, 2024.
EG
Eric Goslau
Executive officer and director
Earlier filings also listed William Goslau (director, last listed Nov 2019), Ted Tarasow (director, last listed Nov 2019), Chad Frederickson (chief financial officer & executive vice president, last listed Nov 2019) and Larry Lawson (director, last listed Oct 2018).